Furthermore, knockdown of Smad4 promoted the expression of stem cell markers CD44, Sox2, Oct4, and Nanog in CRC cells, while the treatment with CD55-Smad4 downregulated their expressions (Figure 4E). This evidence concerns the gene SMAD4 and colorectal carcinoma.